Here, rescue experiments revealed that STXBP6 silencing partly reversed circ_0002346 overexpression-induced antitumor effects in NSCLC cells, demonstrating that circ_0002346 overexpression restrained NSCLC progression partly by upregulating STXBP6. The gene discussed is STXBP6; the disease is non-small cell lung carcinoma.